Estimating Recurrence Risk in Resected Early-Stage Epidermal Growth Factor Receptor-Positive Non-Small Cell Lung Cancer

JAMA Netw Open. 2021 Nov 1;4(11):e2132860. doi: 10.1001/jamanetworkopen.2021.32860.
No abstract available

Publication types

  • Comment

MeSH terms

  • Carcinoma, Non-Small-Cell Lung* / diagnosis
  • Carcinoma, Non-Small-Cell Lung* / epidemiology
  • Carcinoma, Non-Small-Cell Lung* / surgery
  • ErbB Receptors / genetics
  • Humans
  • Lung Neoplasms* / diagnosis
  • Lung Neoplasms* / epidemiology
  • Lung Neoplasms* / pathology
  • Neoplasm Staging

Substances

  • ErbB Receptors